Results
1 -
5 of
5Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach. Grimmett, M. R., Science of Synthesis, (2002) 12, 575..
From Benzofuroxans, Science of Synthesis